ReviewCurrent urology reports2025
Reviewing the Current State of Renal Cell Carcinoma with a Tumor Thrombus: Epidemiology, Pathophysiology, Metastasis, and Systemic Therapy.
Review in Current urology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.Frontiers in immunology · 2025Pooled it
- Cytoreductive Nephrectomy and Thrombectomy for Metastatic Renal Cell Carcinoma with Venous Tumor Thrombus: Experience from a High-Volume Center.Annals of surgical oncology · 2026Article
- Robot‑assisted versus open radical nephrectomy and venous tumor thrombectomy: perioperative and oncologic outcomes-an inverse probability of treatment weighting analysis.Surgical endoscopy · 2026Article
- The Silent Giant: Asymptomatic Renal Cell Carcinoma With a Level III Inferior Vena Cava Thrombus.Cureus · 2026Article
- Article
- Large sarcomatoid chromophobe renal cell carcinoma with tumor thrombus extending into the inferior vena cava: a case report on the challenges and lessons from a fatal outcome.Annals of translational medicine · 2026Article
- Identification of risk factors for the development and prognosis of bone metastases in renal cell carcinoma: development and validation of a predictive model.American journal of cancer research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThe purpose of this review is to highlight relevant literature on the epidemiology and pathophysiology of renal cell carcinoma with a tumor thrombus (RCC-TT), metastatic management, and the role of systemic therapy (ST). RECENT
findingsCurrent research indicates different prevalences and presentations by geography, with many classification systems for RCC-TT. Pathophysiology remains poorly understood for TT formation. Some patients may benefit from cytoreductive nephrectomy with tumor thrombectomy (CN-TT) as well as ST administration, but this population is poorly defined. RCC-TT is a complex disease to manage and lacks high-powered publications relative to RCC without a TT. Future research should focus on the genetics behind TT formation and propagation, CN-TT outcomes, and which patients should receive ST and the optimal timing/dosage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.